Portage, MI, United States of America

David W Piotrowski

USPTO Granted Patents = 42 


 

Average Co-Inventor Count = 5.3

ph-index = 12

Forward Citations = 478(Granted Patents)


Location History:

  • Bear, DE (US) (1996 - 1997)
  • Portage, MI (US) (2002 - 2007)
  • Groton, CT (US) (2007 - 2008)
  • Waterford, CT (US) (2005 - 2024)

Company Filing History:


Years Active: 1996-2025

Loading Chart...
Loading Chart...
Loading Chart...
42 patents (USPTO):

Title: David W. Piotrowski: Innovating in Pharmaceutical Chemistry

Introduction

David W. Piotrowski, a prominent inventor based in Portage, MI, has made significant contributions to the field of pharmaceutical chemistry. With a remarkable portfolio of 39 patents, his work primarily focuses on the development of novel chemical compounds with potential therapeutic applications.

Latest Patents

Among his latest patents, Piotrowski has developed innovative pyrazole derivatives aimed at treating sickle cell disease (SCD) through HbS modulators. This invention encompasses not only the chemical compounds themselves but also their medical applications, processes for preparation, and intermediates utilized in production. Additionally, he has been involved in the creation of GLP-1 receptor agonists, providing 6-carboxylic acids of benzimidazoles as therapeutic agents, outlining methods for administration to mammals in need.

Career Highlights

David Piotrowski has held significant positions in major pharmaceutical companies, including Pfizer Corporation and Pharmacia & Upjohn Company. His extensive experience within these organizations has played a crucial role in shaping his innovative approach to drug discovery and development.

Collaborations

Throughout his career, Piotrowski has worked alongside notable colleagues such as Vincent E. Groppi, Jr. and Eric Jon Jacobsen. These collaborations have fostered an environment of creativity and knowledge sharing, driving advancements in their shared research areas.

Conclusion

David W. Piotrowski stands out as a dedicated inventor whose contributions to pharmaceutical chemistry have the potential to improve healthcare outcomes for patients. His extensive patent portfolio and collaborations reflect a commitment to innovation that continues to influence the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…